Human Endothelin Subtype A Receptor Enhancement during Tissue Culture via de Novo Transcription
- 1 January 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 50 (1) , 127-136
Abstract
Endothelin (ET) has, since its discovery, increasingly been considered a key player in the pathophysiological processes of cerebral vasospasm in the course of subarachnoid hemorrhage, although it remains unclear how ET is involved. We present data that indicate an inherent capacity of human cerebral arteries to change their sensitivity to ET. Human cerebral arteries were obtained from patients undergoing intracranial tumor surgery. The vessels were divided into segments and subjected to organ culture for 48 hours. The vessels were then examined by using in vitro pharmacological methods and molecular biological techniques. After organ culture of the cerebral arteries, both the sensitivity to and potency of ET were enhanced (maximal response, 152 ± 9%; −log (50% effective concentration), 10.3 ± 0.3), in comparison with data for fresh cerebral arteries. Contractions were inhibited by both FR139317 (a specific ETA receptor antagonist) and bosentan (a mixed ETA and ETB receptor antagonist), in a manner indicating the sole presence of contractile ETA receptors. An inconsistent dilative response to the selective ETB receptor agonist sarafotoxin 6c was observed; the response was preserved in some segments and abolished in others, and potentiation of the precontraction was observed in yet other segments. No isolated contractile response to sarafotoxin 6c was observed, however. In reverse transcription-polymerase chain reaction assays, both ETA and ETB receptor messenger ribonucleic acid was detected. These results demonstrate that human cerebral arteries are capable of enhancing the function of ETA receptors.Keywords
This publication has 33 references indexed in Scilit:
- Endothelin and Calcium Signaling1998
- Impairment of the Modulatory Role of Nitric Oxide on the Endothelin-1-elicited Contraction of Cerebral Arteries: A Pathogenetic Factor in Cerebral Vasospasm after Subarachnoid Hemorrhage?Neurosurgery, 1997
- Comparison of the contractile effects and binding kinetics of endothelin-1 and sarafotoxin S6b in rat isolated renal arteryBritish Journal of Pharmacology, 1997
- Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhageJournal of Neurosurgery, 1996
- Plasticity of contractile endothelin‐B receptors in human arteries after organ cultureBritish Journal of Pharmacology, 1996
- Endothelin-A receptors mediate contraction in human cerebral, meningeal and temporal arteriesJournal of the Autonomic Nervous System, 1994
- Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with subarachnoid hemorrhageZeitschrift für Die Gesamte Experimentelle Medizin, 1992
- Enhanced vasoconstrictor effect of endothelin in cerebral arteries from rats with subarachnoid haemorrhageActa Physiologica Scandinavica, 1990
- Acute and long-term effects of tissue culture on contractile reactivity in renal arteries of the rat.Circulation Research, 1989
- Operational models of pharmacological agonismProceedings of the Royal Society of London. B. Biological Sciences, 1983